ARCHIVES

DCT Faces Hard Choices, Clinical Group Need Re-Examination, Chabner tells BSC

This article is from The Cancer Letter archive.

Vol. 08 No. 44 | November 12, 1982

Download PDF Visit The Full Archive

Related Articles

FASEB Report On NIH Funding Urges Sustained Growth In Fiscal Year 2011

April 16, 2010

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

August 4, 1995

Healy Comes To Defense Of NCI’s Robert Wittes; Official Has Been Target Of Innuendo Over Taxo

September 11, 1992

Biotheraputices To Reveal Plans for Expansion

August 8, 1986

In Brief: Staff, Subcommittee Reports Due At NCAB June Meet; CCIRC to Sponsor Symposium On Epidemiology On Oct.

June 6, 1975

NDA n Vp-16 Goes to Advisory Committee Sept. 30

August 27, 1982